Neuropathologie de la sclérose latérale amyotrophique sporadique

Chiò, 2013, Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the publishedliterature, Neuroepidemiology, 41, 118, 10.1159/000351153 Marin, 2014, French register of ALS in Limousin. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe – the French register of ALS in Limousin (FRALim register), Eur J Neurol, 21, 1292, 10.1111/ene.12474 Lill, 2011, Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases, Amyotroph Lateral Scler, 12, 238, 10.3109/17482968.2011.584629 Wang, 2017, Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis, Neurotoxicology, 61, 101, 10.1016/j.neuro.2016.06.015 Camu, 2014, Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis, Neurobiol Aging, 35, 1198, 10.1016/j.neurobiolaging.2013.11.005 EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, 2012, EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) – revised report of an EFNS task force, Eur J Neurol, 19, 360, 10.1111/j.1468-1331.2011.03501.x Chiò, 2009, Prognostic factors in ALS: a critical review, Amyotroph Lateral Scler, 10, 310, 10.3109/17482960802566824 Phukan, 2012, The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study, J Neurol Neurosurg Psychiatry, 83, 102, 10.1136/jnnp-2011-300188 Swinnen, 2014, The phenotypic variability of amyotrophic lateral sclerosis, Nat Rev Neurol, 10, 661, 10.1038/nrneurol.2014.184 Jésus, 2018, Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis, Eur J Neurol, 25, 97, 10.1111/ene.13468 Steyn, 2018, Hypermetabolism in ALS is associated with greater functional decline and shorter survival, J Neurol Neurosurg Psychiatry, 89, 1016, 10.1136/jnnp-2017-317887 Bensimon, 1994, A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole study group, N Engl J Med, 330, 585, 10.1056/NEJM199403033300901 Lacomblez, 1996, Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lancet, 347, 1425, 10.1016/S0140-6736(96)91680-3 Radunović, 2007, Clinical care of patients with amyotrophic lateral sclerosis, Lancet Neurol, 6, 913, 10.1016/S1474-4422(07)70244-2 Gray, 2013, 216 Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 Munoz, 1988, Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients, J Neuropathol Exp Neurol, 47, 9, 10.1097/00005072-198801000-00002 Troost, 1992, Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis, Acta Neuropathol, 84, 664, 10.1007/BF00227744 Borthwick, 1999, Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death, Ann Neurol, 46, 787, 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8 Sasaki, 2007, Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis, J Neuropathol Exp Neurol, 66, 10, 10.1097/nen.0b013e31802c396b Wiedemann, 2002, Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients, J Neurochem, 80, 616, 10.1046/j.0022-3042.2001.00731.x Beal, 1997, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann Neurol, 42, 644, 10.1002/ana.410420416 Ferrante, 1997, Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis, J Neurochem, 69, 2064, 10.1046/j.1471-4159.1997.69052064.x Kuhle, 2009, Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis, Eur J Neurol, 16, 771, 10.1111/j.1468-1331.2009.02560.x Arai, 2006, TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Biochem Biophys Res Commun, 351, 602, 10.1016/j.bbrc.2006.10.093 Mackenzie, 2010, TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia, Lancet Neurol, 9, 995, 10.1016/S1474-4422(10)70195-2 Gitcho, 2008, TDP- 43 A315T mutation in familial motor neuron disease, Ann Neurol, 63, 535, 10.1002/ana.21344 Kabashi, 2008, TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis, Nat Genet, 40, 572, 10.1038/ng.132 Sreedharan, 2008, TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis, Science, 319, 1668, 10.1126/science.1154584 Nelson, 2019, Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report, Brain, 142, 1503, 10.1093/brain/awz099 Mackenzie, 2011, A harmonized classification system for FTLD-TDP pathology, Acta Neuropathol, 122, 111, 10.1007/s00401-011-0845-8 Shiina, 2010, TDP-43 dimerizes in human cells in culture, Cell Mol Neurobiol, 30, 641, 10.1007/s10571-009-9489-9 Afroz, 2017, Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation, Nat Commun, 8, 45, 10.1038/s41467-017-00062-0 Tollervey, 2011, Characterizing the RNA targets and position-dependent splicing regulation by TDP-43, Nat Neurosci, 14, 452, 10.1038/nn.2778 Xiao, 2011, RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS, Mol Cell Neurosci, 47, 167, 10.1016/j.mcn.2011.02.013 Buratti, 2001, Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9, J Biol Chem, 276, 36337, 10.1074/jbc.M104236200 Wang, 2016, The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity, Nat Med, 22, 869, 10.1038/nm.4130 Bentmann, 2013, Stress granules in neurodegeneration-lessons learnt from TAR DNA binding protein of 43kDa and fused in sarcoma, FEBS J, 280, 4348, 10.1111/febs.12287 Hergesheimer, 2019, The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?, Brain, 142, 1176, 10.1093/brain/awz078 Chang, 2013, Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function, FEBS Lett, 587, 575, 10.1016/j.febslet.2013.01.038 Shodai, 2013, Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43kDa (TDP-43), J Biol Chem, 288, 14886, 10.1074/jbc.M113.451849 Guo, 2011, An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formationand neurotoxicity, Nat Struct Mol Biol, 18, 822, 10.1038/nsmb.2053 Nonaka, 2013, Prion-like properties of pathological TDP-43 aggregates from diseased brains, Cell Rep, 4, 124, 10.1016/j.celrep.2013.06.007 Scotter, 2014, Differential roles of the ubiquitin proteasome system and autophagy in the clearance of solubleand aggregated TDP-43 species, J Cell Sci, 127, 1263 Feiler, 2015, TDP-43 is intercellularly transmitted across axon terminals, J Cell Biol, 211, 897, 10.1083/jcb.201504057 Iguchi, 2016, Exosome secretion is a key pathway for clearance of pathological TDP-43, Brain, 139, 3187, 10.1093/brain/aww237 Zhang, 2009, Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity, Proc Natl Acad Sci U S A, 106, 7607, 10.1073/pnas.0900688106 Fang, 2014, Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients, Nat Commun, 5, 4824, 10.1038/ncomms5824 Onesto, 2016, Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts, Acta Neuropathol Commun, 4, 47, 10.1186/s40478-016-0316-5 Wang, 2013, The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons, Hum Mol Genet, 22, 4706, 10.1093/hmg/ddt319 Stoica, 2014, ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43, Nat Commun, 5, 3996, 10.1038/ncomms4996 Swarup, 2011, Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways, J Exp Med, 208, 2429, 10.1084/jem.20111313 Kraemer, 2010, Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis, Acta Neuropathol, 119, 409, 10.1007/s00401-010-0659-0 Polymenidou, 2011, Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43, Nat Neurosci, 14, 459, 10.1038/nn.2779 Wu, 2012, Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice, J Biol Chem, 287, 27335, 10.1074/jbc.M112.359000 Iguchi, 2013, Loss of TDP-43 causes age-dependent progressive motor neuron degeneration, Brain, 136, 1371, 10.1093/brain/awt029 Yang, 2014, Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis, Proc Natl Acad Sci U S A, 111, E1121, 10.1073/pnas.1322641111 White, 2018, TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD, Nat Neurosci, 21, 552, 10.1038/s41593-018-0113-5 Strong, 2007, TDP-43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein, Mol Cell Neurosci, 35, 320, 10.1016/j.mcn.2007.03.007 Kim, 2010, Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA, J Biol Chem, 285, 34097, 10.1074/jbc.M110.154831 Lee, 2015, Hyperproduction of IL-6 caused by aberrant TDP-43 overexpression in high-fat diet-induced obese mice, FEBS Lett, 589, 1825, 10.1016/j.febslet.2015.05.040 Ayala, 2011, TDP-43 regulates its mRNA levels through a negative feedback loop, EMBO J, 30, 277, 10.1038/emboj.2010.310 Rosen, 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, 362, 59, 10.1038/362059a0 Rotunno, 2013, An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis, Front Cell Neurosci, 7, 253, 10.3389/fncel.2013.00253 Rakhit, 2004, Monomeric Cu, Znsuperoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis, J Biol Chem, 279, 15499, 10.1074/jbc.M313295200 Ezzi, 2007, Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation, J Neurochem, 102, 170, 10.1111/j.1471-4159.2007.04531.x Bosco, 2010, Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS, Nat Neurosci, 13, 1396, 10.1038/nn.2660 Forsberg, 2010, Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients, PLoS One, 5, e11552, 10.1371/journal.pone.0011552 Paré, 2018, Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis, Sci Rep, 8, 14223, 10.1038/s41598-018-31773-z Liu, 2009, Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis, Ann Neurol, 66, 75, 10.1002/ana.21704 Kerman, 2010, Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form, Acta Neuropathol, 119, 335, 10.1007/s00401-010-0646-5 Da Cruz, 2017, Misfolded SOD1 is not a primary component of sporadic ALS, Acta Neuropathol, 134, 97, 10.1007/s00401-017-1688-8 Mackenzie, 2007, Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations, Ann Neurol, 61, 427, 10.1002/ana.21147 Tyzack, 2019, Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis, Brain, 142, 2572, 10.1093/brain/awz217 Kwiatkowski, 2009, Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis, Science, 323, 1205, 10.1126/science.1166066 Vance, 2009, Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type6, Science, 323, 1208, 10.1126/science.1165942 Dani, 2010, Superresolution imaging of chemical synapses in the brain, Neuron, 68, 843, 10.1016/j.neuron.2010.11.021 Xu, 2013, Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons, Science, 339, 452, 10.1126/science.1232251 Codron, 2021, STochastic Optical Reconstruction Microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain, Neuropathol Appl Neurobiol, 47, 127, 10.1111/nan.12646